title: Psychiatric manifestations of anti-NMDA receptor encephalitis in a man without tumor.
authors.affiliation: Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Doris Hichi
authors.initials: DH
authors.lastname: Kung
authors.forename: Cuie
authors.initials: C
authors.lastname: Qiu
authors.forename: Joseph Shimon
authors.initials: JS
authors.lastname: Kass
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood / Q000134:cerebrospinal fluid / Q000276:immunology*; D001569:Benzodiazepines / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use*; D020363:Limbic Encephalitis / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology*; D000077152:Olanzapine; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*; D000069283:Rituximab; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D014150:Antipsychotic Agents; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D016194:Receptors, N-Methyl-D-Aspartate; D001569:Benzodiazepines; D000069283:Rituximab; D000077152:Olanzapine